Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis

Neuroscience

Volumn 12, Issue 2, 1984, Pages 347-375

  Chesselet, M F ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADENOSINE; ANGIOTENSIN; APOMORPHINE; BRAIN MONOAMINE; CHOLECYSTOKININ; DOPAMINE; GLUTAMIC ACID; GLYCINE; GONADORELIN; NEUROTENSIN; NEUROTRANSMITTER; NORADRENALIN; OPIATE; OXYTOCIN; PRESYNAPTIC RECEPTOR; PROLACTIN; PROTIRELIN; SEROTONIN; SOMATOSTATIN; SUBSTANCE P; VASOPRESSIN;

ANIMAL CELL; BRAIN; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; EIGHTH NERVE NUCLEUS; NERVOUS SYSTEM; NONHUMAN; REVIEW; SUBSTANTIA NIGRA; SYNAPSE;

ACETYLCHOLINE; ANIMAL; BRAIN; CORPUS STRIATUM; DOPAMINE; ENKEPHALINS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATES; GLUTAMIC ACID; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; NEUROTRANSMITTERS; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PITUITARY GLAND, ANTERIOR; SEROTONIN; SUBSTANTIA NIGRA; TRIGEMINAL NUCLEI;

EID: 0021239363     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(84)90058-7     Document Type: Article

References (350)

1. Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism
2. 3H-noradrenaline secretion in guinea-pig vas deferens
3. Cholinergic and dopaminergic mechanisms in Huntington's chorea
4. Presynaptic GABA autoreceptors on GABA-ergic nerve endings of the rat substantia nigra
5. 3H-aminobutyric acid from the rat substantia nigra
6. Morphine and β-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum
7. 3H-noradrenaline from the rat occipital cortex
8. Stereoselectivity of presynaptic autoreceptors modulating dopamine release
9. 3H-dopamine release in the caudate nucleus of the cat: evidence for a role of endogenously released dopamine
10. N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors
11. Vasopressin augments depolarisation-induced release and synthesis of serotonin in hippocampal slices
12. Baclofen selectively inhibits transmission at synapses made by axons of CA3 pyramidal cells in the hippocampal slice
13. The structural specificity of the high affinity uptake ofl-glutamate andl-aspartate by rat brain slices
14. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol
15. Mesocortical dopamine neurons lack of autoreceptors modulating dopamine synthesis
16. Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurons
17. The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas
18. Feedback control of noradrenaline release as a function of noradrenaline concentration in the synaptic cleft in the cortical slices of the rat
19. Further evidence for negative feed-back control of serotonin release in the central nervous system
20. Noradrenaline inhibition of acetylcholine release from guinea-pig brain
21. The monoamine innervation of rat cerebral cortex: synaptic and non-synaptic relationships
22. Intracellular observations on the disinhibitory action of acetylcholine in the hippocampus
23. Effect of prostaglandin E2 on central and peripheral catecholamine neurons
24. Release of the newly synthetized dopamine from dopamine-containing terminals in the striatum of the rat
25. 3H-dopamine synthesis and release in the cat caudate nucleus. Effect ofα-methyl-p-tyrosine and of transection of the nigro-neo-striatal pathway
26. Dopamine modulation of acetylcholine release from the guinea-pig brain
27. Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis
28. Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone
29. Effect of muscimol, a GABA-mimetic agent on dopamine metabolism in the mouse brain
30. Biochemical evidence for a transmitter role of dopamine in the rat hippocampus
31. On the mechanism of presynaptic autoreceptor-mediated inhibition of transmitter synthesis in dopaminergic nerve terminals
32. The raphe nuclei of the cat brain stem: a topographical atlas of their projections as revealed by autoradiography
33. Synaptic relations between cortical and dopaminergic afferents and enkephalin-containing neurons in the neostriatum
34. Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor
35. 14C-GABA release in vitro
36. GABA autoreceptors are not coupled to benzodiazepine receptors in rat cerebral cortex
37. δ-aminolaevulinic acid is a potent agonist for GABA autoreceptors
38. Inhibition of γ-aminobutyric acid release by γ-aminobutyric acid agonist drugs: pharmacology of the γ-aminobutyric acid autoreceptors
39. Modulation of synaptosomal GABA release by enkephalin
40. 3H-acetylcholine from synaptosomes of the myenteric plexus
41. Comparison of effects ofl-DOPA, amphetamine and apomorphine on firing rate of rat dopaminergic neurons
42. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity
43. Beta-adrenergic receptor binding in membrane preparation from mammalian brain
44. GABA receptor binding in rat striatum: localization and effects of denervation
45. Catecholamine receptors on locus coeruleus neurons: Pharmacological characterisation
46. Serotonin release is modulated by presynaptic autoreceptors
47. Neurotransmitter receptor localisations. Brain lesion induced alterations in benzodiazepine, GABA. β-adrenergic and histamine-H1 receptor binding
48. Effect of neurotransmitters on in vitro release of luteinizing hormone releasing hormone from the medio-basal hypothalamus of male rats
49. Dendritic release of dopamine in the substantia nigra
50. Effect of the immunoneutralisation of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons
51. GABA-ergic processes involved in the control of dopamine from nigro-striatal dopaminergic neurons in the cat
52. Morphine and opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus
53. Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat
54. Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei
55. Striatal somatostatin: immunohistochemistry and effects on dopaminergic transmission
56. Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment
57. Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment
58. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase
59. Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurons
60. Release of endogenous amino-acid neurotransmitter candidates from rat olfactory cortex slices: possible regulatory mechanisms and the effects of pentobarbitone
61. Dopamine receptor binding enhancement accompanies lesion-induced behavioural supersensitivity
62. 3H-apomorphine and spiroperidol binding
63. Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors
64. 2 adrenoceptors in rat cerebral cortex: effects of neonatal treatment with 6-hydroxydopamine
65. Biochemical evidence for the presence of presynaptic receptors on dopamine nerve terminals
66. Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine and glutamate
67. Dopamine inhibition of the release of endogenous acetylcholine from corpus striatum and cerebral cortex in tissue slices and synaptosomes: a presynaptic response?
68. Contrasting effects of 5-hydroxytryptamine on the release of dopamine and acetylcholine in the nucleus accumbens of rat
69. Cholinergic action in the nucleus accumbens: Modulation of dopamine and acetylcholine release
70. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens
71. Evidence for presynaptic cholinergic receptors on dopaminergic terminals: degeneration studies with 6-hydroxydopamine
72. Presynaptic modulation of dopamine-induced locomotor activity by oxotremorine in nucleus accumbens of the rat
73. 3H-noradrenaline release from rat brain synaptosomes
74. 3H-noradrenaline release from the rat brain cortex synaptosomes
75. Effects of haloperidol and apomorphine on catecholamine metabolism in brain slices
76. Preferential action of 5-methoxytyramine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: a comparative iontophoretic study with LSD and serotonin
77. Neuronal interactions in the substantia nigra pars reticulata through axon collaterals of the projection neurons: an electrophysiological and morphological study
78. Self-inhibitory dopamine receptors: their role in the biochemical and behavioural effects of low doses of apomorphine
79. Role of GABA neurons in the expression of striatal motor function
80. Presynaptic regulation of the release of catecholamines in the cat hypothalamus
81. 3H-noradrenaline release from slices of rat brain neocortex
82. Cyclic AMP and α-receptor mediated modulation of noradrenaline release from rat brain slices
83. 3H-DA from slices of rat corpus striatum
84. Noradrenergic modulation of glutamate release in the cerebellum
85. The striatum and substantia nigra. A commentary of their relationships
86. Pharmacolgical differences between the alpha-presynaptic adrenoceptors in the peripheral and the central nervous system
87. Cholinergic-anticholinergic antagonism in Parkinsonism
88. 5-hydroxytryptamine receptors in the raphe nucleus of the rat
89. 3H-dopamine release from slices of rat striatum: dependance on slice size
90. Characterisation of inhitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum
91. Noradrenaline stimulates somatostatin release from incubated slices of the amygdala and the hypothalamic preoptic area
92. 3H-monoamines from field-stimulated rat brain slices
93. 3H-5-hydroxytryptamine release from rat brain slices
94. Kainic acid stimulates excitatory amino-acid neurotransmitter release at presynaptic receptors
95. Release-modulating acetylcholine receptors on cholinergic neurons of the guinea-pig ileum
96. 3H-serotonin release from slices of rat hippocampus
97. Trans-synaptic modulation of transmitter release with special reference to adenosine
98. 3H-apomorphine to striatal membrane prepared from rat brain after 6-hydroxydopamine and kainic acid lesions
99. Tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in tissue cultured spinal ganglion neurons from adult mammals
100. Studies on different types of dopamine nerve terminals in the forebrain and their possible interactions with hormones and with neurons containing GABA, glutamate and opioid peptides
101. Enhancement by GABA of glutamate depolarization-induced release from cerebellar nerve-endings
102. Presynaptic inhibition by dopamine receptor agonists of noradrenergic neurotransmission in the rabbit hypothalamus
103. 3H-noradrenaline from rabbit hypothalamus
104. 3H-aminobutyric acid
105. Presynaptic effect ofl-glutamic acid on the release of dopamine in rat striatal slices
106. Stimulation of dopamine release by GABA in rat striatal slices
107. Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat
108. 3H-dopamine in rat striatal slices and cat caudate nucleus
109. The presynaptic stimulatory effect of acetylcholine on dopamine release is suppressed during activation of nigro-striatal dopaminergic neurons in the cat
110. Regulation of dopamine release by nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration
111. 3H-dopamine in rat striatal slices
112. Attempts to localize the GABA receptors involved in the GABA-induced release of newly-synthetized dopamine in rat striatal slices
113. In vivo and in vitro release of dopamine
114. Differentiation of delta and mu opiate receptor localization by light microscopic autoradiography
115. Serotonin receptor-mediated modulation of Ca-dependent 5-hydroxytryptamine release from neurons of the rat brain cortex
116. Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices
117. 2+ induced noradrenaline release from central noradrenergic neurons
118. Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices
119. An immunohistochemical study of enkephalins and other neuropeptides in the striatum of the cat with evidence that the opiate peptides are arranged to form mosaic patterns in register with the striosomal compartment visible by acetylcholinesterase staining
120. Central muscarinic receptor degeneration following 6-hydroxydopamine lesion in the mice
121. Studies on modulation of transmitter release and effector responsiveness in autonomie cholinergic neurotransmission
122. Effects of dopaminergic receptor agonists and antagonists on the activity of the neostriatal cholinergic system
123. 3H-acetylcholine release from slices of rat hippocampus, striatum and cortex
124. 3H-noradrenaline from the hypothalamus
125. Effect of LSD on synthesis and release of 5-HT in rat brain slices
126. 3H-noradrenaline from slices of rat brain neocortex
127. Effect of adenosine on depolarisation induced release of various neurotransmitters from slices of rat corpus striatum
128. Evidence for a γ-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of met-enkephalin elicited by depolarisation
129. Effect of motor and premotor cortex ablation on concentrations of amino-acids, monoamines and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific corticostriatal transmitter
130. On the use of lesions of afferents to localize neurotransmitter receptor sites in the striatum
131. The site of dopamine formation in rat striatum afterl-DOPA administration
132. Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?
133. Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit
134. 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices
135. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin
136. Clonidine-induced inhibition of sympathetic nerve activity no indication for a central presynaptic or an indirect sympathomimetic mode of action
137. Rate and duration of stimulation determine presynaptic effects of haloperidol on dopaminergic neurons
138. Catecholamine uptake by synaptosomes from rat brain: structure activity relationships of drugs with differential effects on dopamine and norepinephrine neurons
139. Presynaptic action of acetylcholine in area Cl of the hippocampus
140. Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis
141. 3H-GABA by slices of rat cerebral cortex
142. Interneurones are probably not involved in the presynaptic dopaminergic control of dopamine release in rabbit caudate nucleus
143. Peptidergic transmission in sympathetic ganglia of the frog
144. Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra
145. Regulation of acetylcholine synthesis and release
146. Substance P release from the rat substantia nigra
147. Opiate analgesics inhibit substance P release from rat trigeminal nucleus
148. 2 and beta-adrenergic receptor subsensitivity
149. 3H-GABA from rat brain slices
150. The in vivo release of acetylcholine from cat caudate nucleus after pharmacological and surgical manipulations of dopaminergic nigro-striatal neurones
151. Effects of (d-alanine, methionine) enkephalinamide on the release of acetylcholine and noradrenaline from brain slices and isolated nerve terminals
152. Presynaptic modulation of the release of dopamine from rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine
153. Muscarinic receptor binding following cholinergic nerve lesions of the cingulate cortex and hippocampus of the rat
154. 3H-atropine binding after 6-OHDA lesion of nigro-striatal neurons
155. Tetrodotoxin resistant electric activity in presynaptic terminals
156. Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity
157. Catecholamine metabolism in rat brain following the intracerebroventricular administration of cyclic nucleotides
158. The site of termination of afferent fibers in the caudate nucleus
159. Effects of ω-aminoacids on tritiated dopamine release from the rat striatum: evidence for a possible glycinergic mechanism
160. 3H-dopamine from slices of rat nucleus accumbens in vitro
161. 3H-dopamine efflux from substantia nigra slices of the rat
162. Modulation by oxotremorine and atropine of acetylcholine release evoked by electrical stimulation of the myenteric plexus of the guinea-pig ileum
163. Inhibition by morphine and β-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro
164. Distribution and release of GABA in the basal ganglia
165. Neurotransmitter uptake: a tool in identifying neurotransmitter-specific pathways
166. Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: correlations with serotonin levels and histochemical fluorescence
167. Increase in acetylcholine levels in vivo by piribedil, a new dopamine receptor stimulator
168. Dopamine receptor: from an in vivo concept towards a molecular characterization
169. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section
170. Presynaptic regulation of the release of catecholamines
171. Citalopram antagonizes the stimulation by lysergic acid diethylamine of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus
172. Presynaptic receptors and mechanisms of action of some hypertensive drugs
173. Reflexly induced inhibition of catecholamine release through a peripheral muscarinic mechanism
174. 3 dopamine receptors
175. 14C-glucose in rat brain cortical and striatal prisms
176. 3H-dopamine release from striatal slices of cat and rat: slight effects of ascorbate
177. 3H-dopamine release in vitro by endogenous acetylcholine
178. The nucleus basalis magnocellularis: the origin of a cholinergic projection to the neocortex of the rat
179. 3H-acetylcholine from rat striatal slices
180. Glutamate as a putative transmitter in the cerebellum: stimulation by GABA of glutamic acid release from specific pools
181. Presynaptic control input to the central nervous system
182. 3H-spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites
183. Evidence for and localization of a unitary dopamine receptor composed by cooperatively linked subunit binding sites in rat striatum
184. 5-enkephalin inhibit the electrically stimulated neurohypophyseal release of vasopressin in vitro: evidence for calcium-dependent opiate action
185. The organisation of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method
186. Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependence
187. Localization of opiate receptors in substantia nigra evidenced by lesion studies
188. β-endorphin in vitro inhibition of striatal dopamine release
189. Endogenous opioid peptides: multiple agonists and receptors
190. Modulation of dopamine release in rat striatal slices by delta opiate agonists
191. Vasoactive intestinal polypeptide and cholinergic mechanisms in cats nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide
192. 3H-aspartate from rat hippocampal slices
193. The roles of noradrenaline and dopamine in contravesive circling behaviour seen after unilateral electrolytic lesion of the locus coeruleus
194. Evidence on the cellular localization of adenyl cyclase in the neostriatum
195. Neostriatal choline acetylase and cholinesterase following selective brain lesions
196. Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs
197. Biochemistry of Alzeimer's dementia
198. Autoregulation of acetylcholine release in isolated hippocampal nerve endings
199. 2 binding sites with those of serotonin autoreceptors which modulate serotonin release
200. Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies
201. 2-adrenoceptors located on serotonergic nerve terminals
202. Evidence for a functional coupling between dopamine reuptake and tyrosine hydroxylation in striatal nerve terminals
203. Adenosine modulation of synaptosomal dopamine release
204. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways
205. 3H-acetylcholine from rat striatal slices: alteration after chronic haloperidol and α-methyl paratyrosine pretreatment
206. The spontaneous and evoked release of acetylcholine from the cerebral cortex
207. A novel GABA receptor modulates stimulus-induced glutamate release from cortico-striatal terminals
208. Benzodiazepines modify the agonist response at a presynaptic GABA receptor
209. 3H-glutamic acid release by dopaminergic drugs
210. Is GABA release modulated by presynaptic receptors?
211. + stimulated release of GABA
212. + and guanine nucleotides
213. The actions of cholinergic drugs on motor nerve terminals
214. Morphine-induced striatal dopamine efflux depends on the activity of nigro-neostriatal dopamine neurons
215. Stimulation by atropine of acetylcholine release and synthesis in cortical slices of rat brain
216. Influence of morphine and naloxone on the release of noradrenaline from rat cerebellar cortex slices
217. Influence of morphine and naloxone on the release of noradrenaline from rat brain
218. Muscarinic presynaptic inhibition of synaptic transmission in myenteric plexus of guinea-pig ileum
219. The distribution and orientation of noradrenergic fibers in neocortex of the rat: an immunofluorescence study
220. 3H-5HT release from rat frontal cortex slices: the effect of 5-HT agonists and antagonists
221. Striatal opiate receptors: pre and postsynaptic localization
222. Presynaptic muscarine receptors and inhibition of release
223. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain
224. Neurotoxic action of capsaicin on spinal substance P neurons
225. Neurophysiological consequences of presynaptic receptor activation: changes in noradrenergic terminal excitability
226. Noradrenergic terminal excitability: effects of opioids
227. Thyrotropin-releasing hormone: action mechanism of an enhanced dopamine release from rat striatal slices
228. Neural association of the limbic system
229. Characteristics of central 5HT receptors and their adaptive changes following intracerebral 5, 7-dihydroxytryptamine administration in the rat
230. Effects of sustained seizures produced by intrahippocampal injections of kainic acid on noradrenergic neurons: evidence for local control of norepinephrine release
231. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and substantiae nigrae in the cat
232. Effect of dorsal rhizotomy on the autoradiographic distribution of opiates and neurotensin receptors and neurotensin-like immunoreactivity within the rat spinal cord
233. Ontogenic development of high potassium and acetylcholine-induced release of dopamine from striatal slices of the rat
234. Dopaminergic neurons: role of presynaptic receptors in the regulation of transmitter biosynthesis
235. The blocking action of baclofen on excitatory transmission in the rat hippocampal slice
236. Ultrastructural demonstration of noradrenergic synapses in the rat central nervous system by dopamine-β-hydroxylase immunocytochemistry
237. + evoked release of met-enkephaline from rat striatum in vitro: effect of putative neurotransmitters and morphine
238. Failure of septal lesions to alter muscarinic cholinergic or benzodiazepine binding sites in hippocampus of rat brain
239. Dopamine synthesis in rat brain striatal synaptosomes: II Dibutyryl cyclic adenosine 3′, 5′-monophosphoric acid and 6-methyltetrahydropterine-induced synthesis increases without an increase in endogenous dopamine release
240. 3H-5 hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain
241. Possible role of cyclic nucleotides in regulation of noradrenaline release from pineal through presynaptic adrenoceptors
242. 3H-noradrenaline from rat occipital cortex slices
243. The effect of prolactine on dopamine release from rat striatum and medial basal hypothalamus
244. Superfusion of the hypothalamus with gamma-aminobutyric acid. Effect of release of noradrenaline and blood pressure
245. B-HT 958, a new α-adrenergic agonist with a high pre/postsynaptic activity ratio
246. Ultrastructural immunohistochemical localisation of tyrosine hydroxylase in the neostriatum
247. Stimulating action of atropine on the release of acetylcholine by rat cerebral cortex in vitro
248. Enkephalin receptors on dopaminergic neurons in rat striatum
249. Electrophysiology of hypothalamic magnocellular neurons secreting oxytocin and vasopressin
250. Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with autoreceptors?
251. Dopaminergic modulation of evoked vasopressin release from isolated neurohypophysis of the rat. Possible involvement of endogenous opioids
252. Do presynaptic receptors control dopamine release?
253. Presynaptic muscarinic receptors increase striatal dopamine release evoked by quasi-physiological depolarisation
254. α-adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of biophase concentration of noradrenaline
255. 2 on catecholamine release from slices of rat and rabbit brain
256. Effect of extracellular dopamine on the release of dopamine in the rabbit caudate nucleus: evidence for a dopaminergic feedback inhibition
257. γ-aminobutyric acid can both inhibit and facilitate dopamine release in the caudate nucleus of the rabbit
258. Adaptative changes in catecholamine receptors in the central nervous system
259. in vitro striatal dopamine release: a β-adrenergic regulated response not mediated by cyclic-AMP
260. A role for striatal beta-adrenergic receptors in the regulation of dopamine release
261. The localization of receptor binding sites in the substantia nigra and the striatum of the rat
262. Localization of dopamine receptors in rat brain
263. 3H-release in the basal ganglia of the cat
264. 3H-5-hydroxytryptamine from rat substantia nigra in vitro
265. 3H-GABA release of rat substantia nigra in vitro
266. 3H-choline and its release from cerebral cortex slices in vitro
267. K-stimulated release of Leu- and met-enkephalin from rat striatal slices: lack of effect of morphine and naloxone
268. 3H-dopamine release from rat striatum: an in vitro model for glutamate actions
269. 3H-dopamine from rat striatal slices
270. 14C-ACh synthesis and release in rat cortical slices
271. Met-enkephalin inhibits in vitro dopamine-induced LHRH release from mediobasal hypothalamus of male rats
272. Avtivation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro
273. 3H dopamine release and its metabolites in rat striatum by nicotinic drugs
274. Mechanism of noradrenaline release from rabbit atria induced by nicotinic agonists
275. + evoked release of methionin enkephalin from rat striatal slices
276. + stimulated release of methionin-enkephalin from slices of rat corpus striatum
277. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity
278. Further evidence for the involvement of D2 but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission
279. 3H-serotonin release in the cerebral cortex
280. 3H noradrenalin release from rat neocortex slices: role of calcium ions and transmitter pools
281. Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum
282. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurones
283. Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine
284. Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity
285. 2-dopamine receptors
286. Thyrotropin-releasing hormone analogs increase dopamine release from rat brain
287. 3H-norepinephrine from rat brain via presynaptic mechanism
288. Synaptosomal uptake and release of dopamine in substantia nigra: effects of γ-aminobutyric acid and substance P
289. 3H-dopamine in rat striatal slices
290. Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity of dopamine agonists
291. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors
292. In vivo evidence for GABA-ergic control of serotonin release in the cat substantia nigra
293. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine
294. Regulation of noradrenaline release by presynaptic receptor systems
295. Presynaptic regulation of release in the central nervous system
296. Effect of dopamine receptor agonists on release of dopamine in the rabbit caudate nucleus in vitro
297. 3H dopamine release from slices of rat substantia nigra and corpus striatum
298. Investigation of possible interactions between substance P and transmitter mechanisms in the substantia nigra and corpus striatum of the rat
299. GABA-mediated potentiation of amine release from nigro-striatal dopamine neurons in vitro
300. Specificity of GABA as a stimulator of dopamine release in rat substantia nigra
301. 3H-dopamine release from superfused rat striatal slices
302. GABA modulates the release of dopamine and acetylcholine from rat caudate nucleus slices
303. Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postysnaptic dopamine receptors in vitro by NN-Dipropyl 56 ADTN
304. + stimulated release of acetylcholine from rat neostriatum
305. in vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine-receptor activity
306. Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus
307. +K evoked efflux of putative neurotransmitters in rat brain
308. Effect of long terml-DOPA administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats
309. Enkephalin-containing neurons in the substantia gelatinosa of trigeminal complex: ultrastructure and synaptic interaction with primary sensory afferents
310. Alpha-adrenoceptor mediated inhibition of brain noradrenergic neurons after acute and chronic treatment with tricyclic antidepressants
311. Lack of effect of morphine in reducing the relase of labelled acetylcholine from brain slices stimulated electrically
312. 3H-acetylcholine from the guinea-pig myenteric plexus: comparison with morphine
313. 3H-acetylcholine from hippocampal slices; effects of septal lesions and of graded concentrations of muscarinic agonists and antagonists
314. Depression of acetylcholine release from cortical slices by cholinesterase inhibition and by oxotremorine
315. Dopaminergic terminal excitability following arrival of the nerve impulse: the influence of amphetamine and haloperidol
316. Schizophrenic symptoms improve with apomorphine
317. Somtaostatin facilitates the serotonin release from rat cerebral cortex, hippocampus and hypothalamus slices
318. Interactions between acetylcholine and dopamine in the basal ganglia
319. Enkephalin, a potential modulator of noradrenalin release in rat brain
320. Presynaptic receptor system on the noradrenergic neurones of rat brain
321. Inhibitory effects of GABA, l-Glutamic acid and nicotine on the potassium-evoked released of substance P in substantia nigra slices of the rat
322. Stimulatory effect of somatostatin on norepinephrine release from rat brain cortex slices
323. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine
324. Modulation of rat brain alpha and beta-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle
325. Presynaptic inhibitory effect of acetylcholine in the hippocampus
326. Calcium dependence of prejunctional inhibitory effects of adenosine and acetylcholine on adrenergic neuro-transmission in canine saphenous veins
327. Presynaptic modulation of neurochemical transmission
328. Modulation of cortical release of acetylcholine by noradrenaline released from nerve arising from the rat locus coeruleus
329. Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurons
330. The inhibitory effects of adenosine and related nucleotides on the release of acetylcholine
331. Presynaptic modulation by norepinephrine and dopamine of acetylcholine release in peripheral and central nervous system
332. Postnatal development of presynaptic alpha-adrenoceptors in rat cerebral cortex: studies with brain slices and synaptosomes
333. 3H-Noradrenaline release from rat brain slices and on its presynaptic α-adrenergic modulation
334. On the capacity of presynaptic alpha-receptors to modulate norepinephrine release from slices of rat neocortex and the affinity of some agonists and antagonists for these receptors
335. Regional rat brain levels of 3, 4 dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurements and influence of drugs
336. 3H-dopamine from rat brain slices
337. 3H-dopamine by potassium and electrical stimulation from rat brain slices
338. Local regulation of adrenergic neurotransmission
339. 3H-dopamine by slices of rat striatum
340. 3H-dopamine from rat striatal slices
341. 3H-dopamine and serotonin from superfused rat striatal slices
342. Muscarinic supersensitivity induced by septal lesions or chronic atropin treatment
343. Reduction by β-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus
344. Enkephalins open potassium channels in mammalian central neurons
345. Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular injection of horeseradish peroxidase
346. Actions of GABA-ergic agents on dopamine metabolism in the nigro-striatal pathway of the rat
347. Intrathecal morphin inhibits substance P release from mammalian spinal cord in vivo
348. Postsynaptic localization of muscarinic cholinergic binding in rat hippocampus
349. Nicotine-induced release of noradrenaline from hypothalamic synaptosomes
350. Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro